🔎 Trials Near Me

Akèy › Timè nan sèvo › New York

Etid klinik pou Timè nan sèvo nan New York

35 etid pou Timè nan sèvo ap chèche patisipan nan sit nan New York.

Vil nan New York

Tèks ofisyèl etid la (Anglè)

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

  • New York University Langone's Perlmutter Cancer Institute, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06991101

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success
  • Columbia University Irving Medical Center, New York
  • Montefiore Medical Center, The Bronx
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0142, Buffalo
  • Local Institution - 0170, New York
  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07492680

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • Icahn School of Medicine at Mount Sinai, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06253871

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

  • Memorial Sloan-Kettering Cancer Center, New York
  • Mayo Clinic_Rochester, Rochester
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07428616

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

  • Stony Brook Cancer Center, Stony Brook
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06764940

Phase I Study of Fractionated Stereotactic Radiation Therapy

  • Montefiore Medical Center, The Bronx
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT03726359

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

  • Albany Medical Center, Albany
  • SUNY Upstate Medical Center, Syracuse
  • Montefiore Einstein, The Bronx
  • ak 1 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT04427384

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • Roswell Park Cancer Institute, Buffalo
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Jul 21, 2026 · NCT04348747

Chronic CED of TPT for Recurrent Malignant Glioma

  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT06666712

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

  • Memorial Sloan Kettering Suffolk - Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT05419076

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • State University of New York Upstate Medical University, Syracuse
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT03550391

CONVIVO Endomicroscopy

  • Northwell Health, Manhasset
Ap rekriteVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Jun 4, 2026 · NCT06087393

European Prospective Investigation Into Childhood Cancer

  • Columbia University Irving Medical Center, New York
Ap rekriteEtid obsèvasyon
Laj 3 a 21 · Tout sèks · Mizajou Jun 2, 2026 · NCT05375617

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

  • Lenox Hill Brain Tumor Center, New York
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT05954858

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

  • Lenox Hill Brain Tumor Center, New York
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT05271240

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

  • Lenox Hill Brain Tumor Center, New York
Ap rekriteFaz 1/2
Laj 18 a 74 · Tout sèks · Mizajou Jun 1, 2026 · NCT03213002

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

  • Lenox Hill Brain Tumor Center, New York
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT05979064

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • Lenox Hill Brain Tumor Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT02861898

A Study of Sotorasib in People With Brain Tumors

  • Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison
  • ak 2 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06807619

Brodalumab in the Treatment of Immune-Related Adverse Events

  • Columbia University Irving Medical Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT06673329

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

  • State University of New York, Downstate, Brooklyn
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Jiska laj 18 · Tout sèks · Mizajou Apr 23, 2026 · NCT04322734

rTMS for Postoperative Brain Tumor Patients

  • Columbia University Irving Medical Center, New York
Ap rekrite
Laj 22 a 65 · Tout sèks · Mizajou Apr 15, 2026 · NCT07530536

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06810544

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • Lenox Hill Brain Tumor Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT02800486

Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • Weill Cornell Medicine, New York
  • Brooklyn Methodist Hospital - NewYork Presbyterian, New York
  • New York Presbyterian Hospital - Queens, New York
Ap rekriteFaz 1/2
Laj 19 a 90 · Fanm · Mizajou Mar 30, 2026 · NCT03449238

Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 6, 2026 · NCT05559853

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 23, 2026 · NCT06058988

FUS Etoposide for DMG

  • Columbia University Irving Medical Center, New York
Ap rekriteFaz 1
Laj 4 a 21 · Tout sèks · Mizajou Jan 28, 2026 · NCT05762419

Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

  • University of Rochester, Rochester
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT04965064

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

  • New York-Presbyterian/Weill Cornell Medical Center, New York
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Nov 24, 2025 · NCT06072807

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Nyack Hospital, Nyack
  • Dickstein Cancer Treatment Center, White Plains
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 8, 2025 · NCT03418961

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • Northshore University Hospital, Manhasset
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Mar 26, 2025 · NCT01906385

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.